Feasibility of Monotherapy by Rituximab Without Additional Desensitization in ABO-incompatible Living-Donor Liver Transplantation
Hidekazu Yamamoto(Kumamoto University), Yukihiro Inomata(Kumamoto University), Yuki Oya(Vanderbilt University Medical Center), Kohei Miura(Kumamoto University), Seiichi Kawabata(Kumamoto University), Shintaro Hayashida(Kumamoto University), Koshi Uchida(Kumamoto University), Kaori Isono(Kumamoto University), Yasuhiko Sugawara(Kumamoto University)
Cited by 31
Related Papers
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
|Journal of Hepatology|2003|1.6k
Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma
|Gastroenterology|2008|765
Prognostic Impact of Anatomic Resection for Hepatocellular Carcinoma
|Annals of Surgery|2005|641
Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test
|Journal of Hepato-Biliary-Pancreatic Surgery|2005|372